Literature DB >> 8904368

Is Burkholderia (Pseudomonas) cepacia disseminated from cystic fibrosis patients during physiotherapy?

E Ensor1, H Humphreys, D Peckham, C Webster, A J Knox.   

Abstract

Burkholderia cepacia is well recognized as a potential respiratory pathogen in cystic fibrosis (CF) patients and there is increasing concern about nosocomial acquisition. Environmental contamination with B. cepacia before, during and after physiotherapy was studied in eight adult CF patients. Air was sampled using a surface air sampler, and horizontal surfaces and pillows were sampled with moistened swabs and contact plates, respectively. Thirty-nine (40%) of 97 air samples were positive and counts ranged from 1-63 cfu/m3. Forty-four percent of samples taken after physiotherapy were positive. B. cepacia was not recovered from sinks or horizontal surfaces but the pillows of three patients were positive. B. cepacia is disseminated into the immediate environment by adult CF patients receiving physiotherapy. The potential risk of person-to-person transmission during hospitalization justifies the recommendation that B. cepacia-positive patients should be segregated from other CF patients.

Entities:  

Mesh:

Year:  1996        PMID: 8904368     DOI: 10.1016/s0195-6701(96)90160-7

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  6 in total

1.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

2.  Environmental sampling to detect Burkholderia cepacia in a cystic fibrosis outpatient clinic.

Authors:  H Humphreys; D Peckhman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-06       Impact factor: 3.267

3.  Absence of Burkholderia cepacia from the respiratory tract of non-cystic fibrosis patients.

Authors:  J Hyde; H Humphreys
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-03       Impact factor: 3.267

Review 4.  Infection control in cystic fibrosis.

Authors:  Lisa Saiman; Jane Siegel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

5.  Surveillance of an adult intensive care unit for long-term persistence of a multi-resistant strain of Acinetobacter baumannii.

Authors:  C A Webster; M Crowe; H Humphreys; K J Towner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-03       Impact factor: 3.267

6.  Physiotherapy for cystic fibrosis in Australia and New Zealand: A clinical practice guideline.

Authors:  Brenda M Button; Christine Wilson; Ruth Dentice; Narelle S Cox; Anna Middleton; Esta Tannenbaum; Jennifer Bishop; Robyn Cobb; Kate Burton; Michelle Wood; Fiona Moran; Ryan Black; Summar Bowen; Rosemary Day; Julie Depiazzi; Katherine Doiron; Michael Doumit; Tiffany Dwyer; Alison Elliot; Louise Fuller; Kathleen Hall; Matthew Hutchins; Melinda Kerr; Annemarie L Lee; Christina Mans; Lauren O'Connor; Ranjana Steward; Angela Potter; Tshepo Rasekaba; Rebecca Scoones; Ben Tarrant; Nathan Ward; Samantha West; Dianne White; Lisa Wilson; Jamie Wood; Anne E Holland
Journal:  Respirology       Date:  2016-04-18       Impact factor: 6.424

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.